Search

Search Constraints

You searched for: Author/Creator Imoto, Shigeru

Search Results

1. A double‐blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy‐induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide. (13th March 2020)

3. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 1 (January 2021)

4. Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. (23rd April 2014)

5. Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy. Issue 1 (December 2016)

6. Establishment of a deep‐learning system to diagnose BI‐RADS4a or higher using breast ultrasound for clinical application. Issue 10 (3rd August 2022)

9. Progesterone receptor expression in proliferating cancer cells of hormone-receptor-positive breast cancer. Issue 10 (November 2018)

10. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial. Issue 1 (January 2016)